• Mycobacterium tuberculosis and the response of its host
• 34 min
  1. The genetic structure of Mycobacterium tuberculosis - insights into genome organisation and evolution of the causative agent of tuberculosis

  • Dr. Roland Brosch
• 36 min
  2. The pathogenesis of tuberculosis

  • Dr. William R. Bishai
• 57 min
  3. Immune response and rational development of vaccines and biomarkers

  • Prof. Dr. Stefan H. E. Kaufmann
• 38 min
  4. Molecular mechanisms of drug resistance in M. tuberculosis

  • Dr. Daniela Cirillo
• The epidemiology of tuberculosis
• 40 min
  5. The basic epidemiology of tuberculosis (TB)

  • Dr. David Dowdy
• 34 min
  6. Global epidemiology of TB

  • Dr. Philippe Glaziou
• 48 min
  7. Social determinants of tuberculosis

  • Dr. Knut Lönnroth
• The control of tuberculosis
• 46 min
  8. Treatment of tuberculosis

  • Dr. Jean-Pierre Zellweger
• 32 min
  9. The End TB Strategy towards TB elimination 1

  • Dr. Mario Raviglione
• 52 min
  10. The End TB Strategy towards TB elimination 2

  • Dr. Mario Raviglione
• 38 min
  11. Financing TB care and control

  • Dr. Christopher Fitzpatrick
  • Dr. Andrea Pantoja
• 27 min
  12. Tuberculosis and COVID-19

  • Prof. Giovanni Battista Migliori
• 36 min
  13. Multidrug resistant tuberculosis (MDR-TB): an update

  • Dr. Simon Tiberi
• 49 min
  14. Impact of HIV on tuberculosis in the developing world and how to manage it

  • Prof. Anthony D. Harries
• 33 min
  15. Reaching the missing millions through public-private mix (PPM) for TB prevention and care

  • Ms. Hannah Monica Dias
• 39 min
  16. TB in children

  • Prof. Ben J. Marais
• 30 min
  17. Community engagement in tuberculosis care

  • Ms. Lana Syed
• 29 min
  18. India: the epicentre of global TB control

  • Dr. Madhukar Pai
• 23 min
  19. Community engagement in TB care

  • Dr. Haileyesus Getahun
• Research and development for new approaches in the control of tuberculosis
• 21 min
  20. Development of new regimens for tuberculosis

  • Dr. Zhenkun Ma
• 35 min
  21. Development, testing and introduction of new diagnostic tools for tuberculosis

  • Dr. Mark Perkins
• 69 min
  22. Pharmacometrics in tuberculosis

  • Prof. Charles A. Peloquin
• 29 min
  23. Extrapulmonary tuberculosis

  • Dr. Scott Heysell
• 27 min
  24. The role of surgery in tuberculosis management

  • Dr. Richard Zaleskis
• Archived Lectures *These may not cover the latest advances in the field
• 28 min
  25. The development of current treatments for tuberculosis

  • Dr. Andrew Nunn
• 47 min
  26. The pathogenesis of tuberculosis

  • Dr. William R. Bishai
• 34 min
  27. Basics of tuberculosis epidemiology

  • Prof. Frank Cobelens
• 40 min
  28. Drug resistance in tuberculosis and its public health management

  • Dr. Paul Nunn
• 57 min
  29. The international approach to the control of tuberculosis

  • Dr. Mario Raviglione
• 35 min
  30. Public-private mix for TB care and control

  • Dr. Mukund Uplekar

Printable Handouts

PDF

Navigable Slide Index

1. Introduction
2. Overview
3. TB transmission and control
4. Stopping TB transmission
5. TB risk factors
6. Fate of a TB epidemic
7. How do we know about the burden of TB?
8. Core indicators of TB burden
9. Sources of data on TB burden
10. Quantification of under-reporting, under-diagnosis
11. Global TB burden and types of epidemics
12. Global burden of TB in 2010
13. Highest numbers of new cases in India and China
14. 22 countries account for 80% of the global burden
15. Highest incidence rates in Africa
16. High levels of HIV-associated TB in Africa
17. TB mortality rates, including deaths in HIV+
18. International TB targets
19. Trends in global TB burden
20. Regional trends in incidence
21. Regional trends in mortality
22. Measuring trends in MDR-TB burden
23. % MDR-TB among new TB cases, 1994-2009
24. Global trends in MDR-TB
25. Countries with at least one XDR-TB case
26. Decline in MDR-TB in Hong Kong
27. Reversal of severe MDR-TB epidemics
28. Effective control, but % MDR remains high
29. Types of TB epidemics
30. Progress in TB control
31. Progress in treatment success
32. HIV testing in TB expanding, but too slowly
33. Insufficient anti-retroviral treatment among TB
34. Low coverage of drug susceptibility testing
35. MDR treated as % of estimated MDR
36. Achievements thus far
37. Impact of TB control
38. Severe economic crisis impact on TB mortality
39. Decline in global Case Fatality Ratio (CFR)
40. Trends in case fatality ratio by region
41. Impact of DOTS on TB prevalence in Cambodia
42. Fast decline in TB mortality in China
43. Can we eliminate TB?
44. TB elimination
45. Preventing TB in 2 billion infected individuals
46. In conclusion
47. References

Topics Covered

• Tuberculosis
• Epidemiology
• Incidence
• Prevalence
• Mortality
• Case fatality
• TB drug resistance
• HIV-associated TB
• Progress in TB control
• Impact of TB control
• TB elimination

Links

Series:

• Tuberculosis

Categories:

• Microbiology

Therapeutic Areas:

• Infectious Diseases
• Respiratory Diseases

Talk Citation

Publication History

• Published on February 28, 2013

Financial Disclosures

• Dr. Philippe Glaziou has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.